The following Blue Cross Blue Shield announcements are just a few of the company activities from December 2023
WAINUA™ for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis is available at Orsini Specialty Pharmacy
CarelonRx, Carelon’s pharmacy benefit manager, announced it will launch digital pharmacy CarelonRx Pharmacy on Jan. 1, 2024
Biologics by McKesson and Onco360 Selected as Specialty Pharmacy Partners for Fruzaqla, Ogsiveo, and Truqap
The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends
AMI offers continuing market research services to clients on Blue Cross Blue Shield Plans as well as publishing an annual Blue Cross Blue Shield Plans Report
AMI’s annual Specialty Hub Service Providers Report provides comprehensive business intelligence on more than 70 companies
Takeda Pharmaceuticals Selects Specialty Pharmacy Partners for new FDA-approved drugs ADZYNMA and FRUZAQLA